Header Logo

Connection

STEPHEN YENZEN LAI to Disease Progression

Back to Details
This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Disease Progression.
STEPHEN YENZEN LAI
Connection Strength
0.075
Disease Progression
  1. Understanding the presence and function of erythropoietin receptors on cancer cells. J Clin Oncol. 2006 Oct 10; 24(29):4675-6.
    View in: PubMed
    Score: 0.033
  2. Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC. J Clin Endocrinol Metab. 2015 Dec; 100(12):E1550-9.
    View in: PubMed
    Score: 0.015
  3. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 Dec 15; 20(24):6582-92.
    View in: PubMed
    Score: 0.014
  4. Sorafenib in metastatic thyroid cancer: a systematic review. Oncologist. 2014 Mar; 19(3):251-8.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.